Cargando…
Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study
SIMPLE SUMMARY: Long-term low-dose aspirin use was associated with a reduced risk of primary cancer in survivors of ischemic cardiac or cerebrovascular disease. Thus, in contrast to the situation for the general population (for which the anticancer effects of aspirin are still controversial), long-t...
Autores principales: | Liao, Yen-Hsiang, Hsu, Ren-Jun, Wang, Tzu-Hwei, Wu, Chen-Ta, Huang, Sheng-Yao, Hsu, Chung-Y., Hsu, Wen-Lin, Liu, Dai-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817941/ https://www.ncbi.nlm.nih.gov/pubmed/36612095 http://dx.doi.org/10.3390/cancers15010097 |
Ejemplares similares
-
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
por: Liao, Yen-Hsiang, et al.
Publicado: (2020) -
Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study
por: Lin, Shih-Yi, et al.
Publicado: (2018) -
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2019) -
Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study
por: Peng, Tzu-Rong, et al.
Publicado: (2021) -
Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020)